Technology Offerings

Innovative miR-29 Antagonists for Aortic Aneurysm Treatment

The present invention relates to the use of antagonists of the miR-29 family to prevent and/or treat aortic aneurysms and rupture of atherosclerotic plaques.

Further Information: PDF

INNOVECTIS Gesellschaft für Innovations-Dienstleistungen mbH
Phone: +49 (0)69/2561632-0

Contact
Dr. Otmar Schöller

Comments (0)

Write a comment